Concepedia

LA Wenning

LW

4

Publications

455

Citations

4

H-Index

2007

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Canada Inc. (Canada)

Thomas Jefferson University

United States Military Academy

LA Wenning is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).

Publications per year

2007–2009

4

Publications

4

Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects

Marian Iwamoto, LA Wenning, AS Petry et al. · Clinical Pharmacology & Therapeutics · 2007 · 169 citations

Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1

Eseng Lai, Inge De Lepeleire, TM Crumley et al. · Clinical Pharmacology & Therapeutics · 2007 · 149 citations

Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms

LA Wenning, AS Petry, JT Kost et al. · Clinical Pharmacology & Therapeutics · 2009 · 90 citations

Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist

Eseng Lai, LA Wenning, TM Crumley et al. · Clinical Pharmacology & Therapeutics · 2007 · 47 citations

Rows per page

1–4 of 4